Metabolic activation of the new tricyclic antidepressant tianeptine by human liver cytochrome P450.

[1]  G. Labbe,et al.  Metabolic activation of the antidepressant tianeptine. II. In vivo covalent binding and toxicological studies at sublethal doses. , 1989, Biochemical Pharmacology.

[2]  G. Labbe,et al.  Metabolic activation of the antidepressant tianeptine. I. Cytochrome P-450-mediated in vitro covalent binding. , 1989, Biochemical pharmacology.

[3]  D. Pessayre,et al.  Inhibitory effects of nilutamide, a new androgen receptor antagonist, on mouse and human liver cytochrome P-450. , 1989, Biochemical pharmacology.

[4]  O. Sabouraud,et al.  Lack of pharmacokinetic influence on levodopa by bromocriptine. , 1988, Clinical neuropharmacology.

[5]  A. Prox,et al.  Amitriptyline metabolites in human urine. Identification of phenols, dihydrodiols, glycols, and ketones. , 1987, Drug metabolism and disposition: the biological fate of chemicals.

[6]  C. Bonfils,et al.  Expression of five forms of microsomal cytochrome P-450 in primary cultures of rabbit hepatocytes treated with various classes of inducers. , 1987, Biochemical pharmacology.

[7]  D. Pessayre,et al.  Metabolic activation of the tricyclic antidepressant amineptine by human liver cytochrome P-450. , 1987, Biochemical pharmacology.

[8]  T. Kronbach,et al.  High-performance liquid chromatographic assays for bufuralol 1'-hydroxylase, debrisoquine 4-hydroxylase, and dextromethorphan O-demethylase in microsomes and purified cytochrome P-450 isozymes of human liver. , 1987, Analytical biochemistry.

[9]  D. Pessayre,et al.  Inactivation of human liver cytochrome P-450 by the drug methoxsalen and other psoralen derivatives. , 1987, Biochemical pharmacology.

[10]  D. Pessayre,et al.  Metabolic activation of the tricyclic antidepressant amineptine--II. Protective role of glutathione against in vitro and in vivo covalent binding. , 1987, Biochemical pharmacology.

[11]  D. Pessayre,et al.  Metabolic activation of the tricyclic antidepressant amineptine--I. Cytochrome P-450-mediated in vitro covalent binding. , 1987, Biochemical pharmacology.

[12]  S. Otton,et al.  Imipramine demethylation and hydroxylation: Impact of the sparteine oxidation phenotype , 1986, Clinical pharmacology and therapeutics.

[13]  R. Branch,et al.  Genetically determined polymorphisms in drug oxidation , 1986, Hepatology.

[14]  L. Bertilsson,et al.  Amitriptyline metabolism: Association with debrisoquin hydroxylation in nonsmokers , 1986, Clinical pharmacology and therapeutics.

[15]  T. Guenthner.  Selective inhibition and selective induction of multiple microsomal epoxide hydrolases. , 1986, Biochemical pharmacology.

[16]  P. Watkins,et al.  Demonstration in multiple species of inducible hepatic cytochromes P-450 and their mRNAs related to the glucocorticoid-inducible cytochrome P-450 of the rat. , 1985, Molecular pharmacology.

[17]  P. Watkins,et al.  Identification of the cytochrome P-450 induced by macrolide antibiotics in rat liver as the glucocorticoid responsive cytochrome P-450p. , 1985, Biochemistry.

[18]  W. Kalow,et al.  A human cytochrome P-450 characterized by inhibition studies as the sparteine-debrisoquine monooxygenase. , 1984, Canadian journal of physiology and pharmacology.

[19]  D. Pessayre,et al.  Effects of erythromycin on hepatic drug-metabolizing enzymes in humans. , 1983, Biochemical pharmacology.

[20]  L. Bertilsson,et al.  E‐ and Z‐10‐hydroxylation of nortriptyline: Relationship to polymorphic debrisoquine hydroxylation , 1981, Clinical pharmacology and therapeutics.

[21]  H. Remmer,et al.  Irreversible protein binding of [14-C]imipramine with rat and human liver microsomes. , 1975, Biochemical pharmacology.

[22]  A. Conney.  Pharmacological implications of microsomal enzyme induction. , 1967, Pharmacological reviews.

[23]  T. Omura,et al.  THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. I. EVIDENCE FOR ITS HEMOPROTEIN NATURE. , 1964, The Journal of biological chemistry.

[24]  Oliver H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[25]  M. J. Coon,et al.  The P450 superfamily: updated listing of all genes and recommended nomenclature for the chromosomal loci. , 1989, DNA.

[26]  A. Kamoun,et al.  Analysis of the side effects of tianeptine. , 1988, Clinical neuropharmacology.

[27]  T. A. Connors,et al.  In vitro covalent binding of cismethrin, bioresmethrin, and their common alcohol to hepatic proteins. , 1985, Toxicology and applied pharmacology.

[28]  B. H. Ch. Stricker,et al.  Drug-induced Hepatic Injury , 1985 .

[29]  M. Horning,et al.  Metabolism of carbamazepine. , 1982, Drug metabolism and disposition: the biological fate of chemicals.